Литература
1. Brown G.C., Magargal L.E., Schachat A., Shah H. Neovascular glaucoma. Etiologic considerations // Ophthalmology. – 1984. – V. 91. – P. 315-320.
2. Michaelson I.C. The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal disease // Trans. Opthalmol. Soc. UK. – 1948. – V. 68. – P. 137-180.
3. Loughman M.S., Chatzistefanou K., Gonzalez E.M. et al. Experimental corneal neovascularisation using sucralfate and basic fibroblast growth fac-tor // Aust. N. Z. J. Ophthalmol. – 1996. – V. 24. – P. 289-295.
4. Amano S., Rohan R., Kuroki M., Tolentino M., Adamis A.P. Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization // Invest. Ophthalmol. Vis. Sci. – 1998. – V. 39. – P. 18-22.
5. Lee D.H., Cho H.J., Kim J.T., Choi J.S., Joo C.K. Expression of vascular endothelial growth factor and inducible nitric oxide synthase in pterygia // Cornea. – 2001. – V. 20. – P. 738-742.
6. Jin J., Guan M., Sima J. et al. Decreased pigment epithelium-derived factor and increased vascular endothelial growth factor levels in pterygia // Cornea. – 2003. – V. 22. – P. 473-477.
7. Senger D.R., Ledbetter S.R., Claffey K.P., Papadopoulos-Sergiou A. et al. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mecha-nisms involving the alphav-beta3 integrin, osteopontin, and thrombin // Am. J. Pathol. – 1996. – V. 149. – P. 293-305.
8. Ferrara N., Houck K.A., Jakeman L.B., Winer J., Leung D.W. The vascular endothelial growth factor family of polypeptides // J. Cell. Biochem. – 1991. – V. 47. – P. 211-218.
9. Dvorak H.F., Brown L.F., Detmar M., Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis // Am. J. Pathol. – 1995. – V. 146. – P. 1029—1039.
10. Aiello L.P., Wong J.S. Role of vascular endothelial growth factor in diabetic vascular complications // Kidney. Int. Suppl. – 2000. – V. 77. – P.113-119.
11. de Vries C., Escobedo J.A., Ueno H., Houck K., Ferrara N., Williams L.T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor // Science. – 1992. – V. 255. – P. 989-991.
12. Meyer-Schwickerath R., Pfeiffer A., Blum W.F. et al. Vitreous levels of the insulin-like growth factots I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondi-abetic and diabetic subjects // J. Clin. Invest. – 1993. – P. 2620—2625.
13. Hanneken A., de Juan E. Jr., Lutty G.A., Fox G.M. et al. Altered distribution of basic fibroblast growth factor in diabetic retinopathy // Arch. Ophthalmol. – 1991. –V. 102. – P. 1005—1011.
14. Aiello L.M., Wand M., Liang G. Neovascular glaucoma and vitreous hemorrhage after cataract surgery in patients with diabetes mellitus // Ophthal-mology. – 1983. – V. 90. – P. 814-820.
15. Rice T.A., Michels R.G., Maguire M.G. Rice E.F. The effect of neovascular glaucoma after vitrectomy for diabetic retinopathy // Am. J. Ophthalmol. – 1983. – V. 95. – P. 1-11.
16. Weinreb R.N., Wasserstrom J.P., Parker W. Neovascular glaucoma following neodymium-YAG laser posterior capsulotomy // Arch. Ophthalmol. – 1986. – V. 104. – P. 730-731.
17. John T., Sassani J.W., Eagle R.C. The myofibroblastic component of rubeosis iridis // Ophthalmology. – 1983. – V. 90. – P. 721-728.
18. Gartner S., Taffet S., Friednan A.H. The association of rubeosis iridis with endothelielisation of the anterior chamber: report of a clinical case with histopathological review of 16 additional cases // Br. J. Opthalmol. – 1977. – V. 61. – P. 267-271.
19. Vestinielsen N. The prevalence of glaucoma and ocular hypertension in type 1 and 2 diabetes mellitus // Acta ophthalmol. – 1983. – Vol. 61. – No. 4. – P. 662-672.
20. Browning D.J., Scott A.Q., Peterson C.B., et al. The risk of missing angle neovascularization by omitting screening gonioscopy in acute central retinal vein occlusion // Ophthalmology. – 1998. – V. 105. – P. 776-784.
21. Sanborn G.E., Symes D.J., Magargal L.E. Fundus iris fluorescein angiography: eva-luation of its use in the diagnosis of rubeosis iridis // Ann. Oph-thalmol. – 1986. – V. 18. – P. 52-58.
22. Ohnishi Y., Ishibashi T., Sagawa T. Fluorescein gonioangiography in dia-betic neovascularisation // Graefes Arch. Clin. Exp. Ophthalmol. – 1994. – V. 232. – P. 199-204.
23. Maruyama Y., Kishi S., Kamei Y. et al. Infrared angiography of the anterior ocular segment // Surv. Ophthalmol. – 1995. – V. 39, Suppl. 1:S40-48.
24. Larsson J., Andreasson S., Bauer B. Cone b-wave implicit time as an early predictor of rubeosis in central retinal vein occlusion // Am. J. Ophthalmol. – 1998. – V. 125. — P. 247-249.
25. Breton M.E., Quinn G.E., Keene S.S. et al. Electroretinogram parameters at presentation patients // Ophthalmology. – 1989. – V. 96. – P. 1343—1352.
26. Kaye S.B., Harding S.P. Early electroretinography in unilateral central retinal vein occlusion as a predictor of rubeosis iridis // Arch. Ophthalmol. – 1988. – V. 106. – P. 353-356.
27. Lettle H.L., Rosenthal A.R., Dellaporta A., Jacobson D.R. The effect of panretinal photocoagulation on rubeosis iridis // Am. J. Ophthalmol. – 1976. – V. 81. – P. 804-809.
28. Pavan P.R., Folk J.C., Weingeist T.A. et al. Diabetic rubeosis and panretinal phothocoagulation. A prospective, controlled, masked trial using iris fluorescein angiography // Arch. Ophthalmol. – 1983. – V. 101. – P. 882-884.
29. Striga M., Ivanisevic M. Comparison between efficacy of full- and mild-scatter (panretinal) photocoagulation on the course of diabetic rubeosis iridis // Ophthalmologica. – 1993. – V. 207. – P. 144-147.
30. Allen R.C., Bellows A.R., Hutchinson B.T., Murphy S.D. Filtration surgery in the treatment of neovascular glaucoma // Ophthalmology. – 1982. – V. 89. – P. 1181—1187.
31. Rodgin S.G. Neovascular glaucoma associated with uveitis // J. Am. Optom. Assoc. – 1987. – V. 58. – P. 499-503.
32. Smith R.J. Rubeotic glaucoma // Br. J. Ophthalmol. – 1981. – V. 65. – P. 606-609.
33. Fernandez-Vigo J., Castro J., Macarro A. Diabetic iris neovascularization. Natural history and treatment // Acta Opthalmol. Scand. – 1997. – V. 75. – P. 89-93.
34. Sihota R., Sandramouli S., Sood N.N. A prospective evaluation of anterior retinal cryoablation in neovascular glaucoma // Ophthalmic. Surg. – 1991. – V. 22. – P. 256-259.
35. Stefaniotou M., Paschides C.A., Psilas K. panretinal cryopexy for the management of neovascularization of the iris // Ophthalmologica. – 1995. –V. 209. – P. 141-144.
36. McHung J.D.A., Marshall J., ffytche T.J. et al. Initial clinical experience using a diode laser in the treatment of retinal vascular disease // Eye. – 1989. – V. 3. – P. 516-527.
37. Flaxel C.J., Larkin G.B., Broadway D.B. et al. Peripheral transscleral retinal diode laser for rubeosis iridis // Retina. – 1997. – V. 17. – P. 421-429.
38. Molteno A.C.B., Bosma N.J., Kittelson J.M. Otago glaucoma surgery out-come study: Long-term results of trabeculectomy – 1976 to 1995 // Ophthalmology. – 1999. – V. 106. – P. 1742—1750.
39. Hurwitz H., Fehrenbacher L., Novotny W. et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer // N. Engl. J. Med. – 2004. – V. 350. – P. 2335—2342.
40. Oshima Y., Sakagychi H., Gomi F., Tano Y. Regression of iris neovascular-ization after intravitreal injection of bevacizumab in patient with proliferative diabetic retinopathy // Am. J. Ophthalmol. – 2006. – V. 142. – P. 155-158.
41. Rosenfeld P.J., Fung A.E., Puliafito C.A. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for macular edema from central retinal vein occlusion // Ophthalmol. Surg. Lasers Imag-ing. – 2005. – V. 36. – P. 336-339.
42. Rosenfeld P.J., Moshfeghi A.A., Pulia-fito C.A. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for ne-ovascular age-related macular degeneration // Ophthalmol. Surg. Lasers Im-aging. – 2005. – V. 36. – P. 331-335.
43. Avery R.L., Pieramici D.J., Rabena M.D., Castellarin A.A., Nasir M.A., Giust M.J. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration // Ophthalmology. – 2006. – V. 113. – P. 363-372.
44. Kahook M.Y., Schuman J.S., Noecker R.J. Intravitreal bevacizumab in a patient with neovascular glaucoma // Ophthalmol. Surg. Lasers Imaging. – 2006. – V. 37. – P. 144-146.
45. Davidorf F.H., Mouser J.G., Derick R.J. Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection // Retina. – 2006. –V. 26. – P. 354-356.
46. Tripathi R.C., Li J., Treipathi B.J., Chalam K.V., Adamis A.P. Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma // Ophthalmology. – 1998. – V. 105. – P. 232-237.
47. Iliev M.E., Doming D., Wolf-Schnurrbursch U., Wolf S., Sarra G.M. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma // Am. J. Ophthalmol. – 2006. – V. 142. – P. 1054—1056.
48. Grisanti S., Biester S., Peters S., Tatar O., Ziemssen F., Bartz-Schmidt K.U., for the Tuebingen Bevacizumab Study Group. Intracameral bevacizumab for iris rubeosis // Am. J. Ophthalmol. – 2006. – V. 142. – P. 158-160.
49. Avery R.L. Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment // Retina. – 2006. – V. 26. – P. 352-354.
50. Silva Paula J., Jorge R., Alves Costa R., Rodrigues Mde L., Scott I.U. Short-term result of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma // Acta Ophthalmol. Scand. – 2006. – V. 84. – P. 556-557.
51. Mason J.O., Albert M.A., Mays A., Vail R. Regression of neovascular iris vessels by intravitreal injection of bevacizumab // Retina. – 2006. – V. 26. – P. 839-841.
52. Gheith M.E., Siam G.A., de Barros D.S. et al. Role of intravitreal bevacizumab in neovascular glaucoma // J. Ocul. Pharmacol. Ther. – 2007. – V. 23. – P. 487-491.
53. Yazdani S., Hendi K., Parkravan M. Intavitreal bavacizumab (Avastin) injection for neovascular glaucoma // J. Glaucoma. – 2007. – V. 16. – P. 437-439.
54. Tsai J.C., Feuer W.J., Parrish R.K., Grajewski A.L. 5-Fluorouracil filtering surgery and neovascular glaucoma. Long-term follow-up of the original pilot study // Opthalmology. – 1995. – V. 102. – P. 887-892.
55. Katz G.J., Higginbotham E.J., Lichter P.R. et al. Mitomycin C versus 5-fluorouracil in high-risk glaucoma filtering surgery. Extended follow-up // Ophthalmology. – 1995. – V. 102. – P. 1263—1269.
56. Lloyd M.A., Heuer D.K., Baerveldt G. et al. Combinet Molteno implantation and pars plana vitrectomy for neovascular glaucomas // Ophthalmology. – 1991. – V. 98. – P. 1401—1405.
57. L’Esperance F.A. Jr., Mittl R.N., James W.A.Jr. Carbon dioxide laser trabeculostomy for the treatment of neovascular glaucoma // Ophthalmology. – 1983. – V. 90. – P. 821-829.
58. Brouillette G., Chebil A. Long-term results of modified trabeculectomy with Supramid implant for neovascular glaucoma // Can. J. Ophthalmol. – 1987. – V. 22. – P. 254-256.
59. Lahey J.M., Fong D.S., Kearney J. Intravitreal tissue plasminogen activator for acute central retinal vein occlusion // Ophthalmic. Surg. Lasers. – 1999. – V. 30. – P. 427-434.
60. Eid T.E., Katz L.J., Spaeth G.L., Augsburger J.J. Tube-shunt surgery versus neodymium-YAG cyclophotocoagulation in the management of neovascular glaucoma // Ophthalmology. – 1997. –V. 104. – P. 1692—1700.
61. Батманов Ю.Е., Мовшович А.И., Нестеров А.П., Серов А.А. Фильтрующая склерцикловитрэктомия в лечении неоваскулярной глаукомы // Вестн. офтальмол. – 1985. – № 3. – С. 6-9.
62. Тахчиди Х.П., Иванов Д.И., Стренев Н.В. Современные технологии хирургии первичной глаукомы // II Евро-Азиатская конф. по офтальмохирургии: Материалы. – Екатеринбург, 2001. – С. 106-107.
63. Иванов Д.И., Тахчиди Х.П., Стренев Н.В. Развитие операции трансцилиарного дренирования задней камеры глаза при глаукомах с органическим блоком угла передней камеры // VII съезд офтальмологов России: Тез. докл. – М., 2000. – Ч. 1. – С. 135-136.
64. Шкворченко Д.О., Каштан О.В. Трансцилиарное дренирование задней камеры с витрэктомией и круговой периферической криопексией сетчатки в сечении неоваскулярной глаукомы // Современные технологии лечения витреоретинальной патологии: Сб. науч. ст. – М., 2002. – С. 318-321.
65. Montero A.C.B. New implant for drainage in glaucoma. Clinical trial // Brit. J. Ophthalmol. – 1969. – V. 53. – P. 506-615.
66. Krupin J., Podos S.M., Becker B., Newkirk J.B. Valve implants in filtering surgery (a preliminary report) // Amer. J. Ophthalmol. – 1976. – V. 81. – P. 232-235.
67. Астахов Ю.С., Егоров Е.А., Астахов С.Ю., Брезель Ю.А. Хирургическое лечение «рефрактерной» глаукомы // Клинич. офтальмология. – 2006. – Т. 7. – № 1. – С. 25-27.
68. Assaad M.H., Baerveldt G., Rockwood E.J. Glaucoma drainage devices: pros and cons // Curr. Opin. Ophthalmol. – 1999. – V. 34. – P. 349-352.
69. Sidoti P.A., Dunphy T.R., Baerveldt G. et al. Experience with the Baerveldt glaucoma implant in treating neovascular glaucoma // Ophthalmology. – 1995. – V. 102. – P. 1107—1118.
70. Luttrull J.K., Avery R.L. Peripheral transscleral retinal diode laser for rube-osis iridis [letter] // Retina. – 1998. – V. 18. – P. 389.
71. Scott I.U., Alexandrakis G., Flynn H.W. Jr. et al. Combined pars plana vitrectomy and glaucoma drainage implant placement for refractory glaucoma // Am. J. Ophthalmol. – 2000. – V. 129. – P. 334-341.
72. Сапрыкин П.Н., Александрова Н.Н., Мышкина Е.Ю., Ляхович В.В. Сравнительная оценка хирургического лечения глаукомы с использованием эксплантодренажей // Актуальные проблемы современной офтальмологии: Сб. науч. трудов. – Смоленск, 1995. – С. 153-155.
73. Черкунов Б.Ф. Лавсановый дренаж передней камеры при фистулизирующих операциях // Всероссийский съезд офтальмологов, 2-й: Материалы. – М., 1968. – С. 431-432.
74. Бедило В.Я. О применении пластмасс для дренажа передней камеры в эксперименте // Всероссийский съезд офтальмологов, 2-й: Материалы. – М., 1968. – С. 412-414.
75. Животовский Д.С. Сравнительная оценка дренажа передней камеры глаза пластмассовой трубкой в хирургическом лечении запущенных стадий глаукомы (экспериментально-клиническое исследование): Дис. … канд. мед. наук. – Астрахань, 1966. – 105 с.
76. Honrubia F.M., Gomez M.L., Hernandez A., Grijalbo M.P. Long-term results of silicone tube in filtering surgery for eyes with neovascular glaucoma // Am. J. Ophthalmol. – 1984. – V. 97. – P. 501-504.
77. Lavin M.J., Franks W.A., Wormald R.P., Hitchings R.A. Clinical risk factors for failure in glaucoma tube surgery. A comparison of three tube designs // Arch. Ophthalmol. – 1992. – V. 110. – P. 480-485.
78. Тахчиди Х.П., Балашевич Л.И., Науменко В.В., Качурин А.Э. Применение лейкосапфирового эксплантодренажа в хирургическом лечении больных с рефрактерными формами глаукомы (учебно-методическое пособие). – Санкт-Петербург. – 2007. – 31 с.
79. Тахчиди Х.П., Балашевич Л.И., Науменко В.В., Качурин А.Э., Волик А.А. Отдаленные результаты хирургического лечения больных с рефрактерными формами глауком с применением лейкосапфирового эксплантодренажа // Инновационная офтальмология: Сб. науч. трудов. – Краснодар, 2010. – С. 140-141.
80. Jonas J.B., Spandau U.H., Schlichtenbrede F. Intravitreal bevacizumab for filtering surgery // Ophthalmic. Res. – 2007. – V. 39. – P. 121-122.
81. Eid T.M., Radwan A., Manawy W., Hawary I. Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: safety and efficacy // Can. J. Ophthalmol. – 2009. – V. 44. – P. 451-456.
82. Beckman H., Waeltermann J. Transscleral ruby laser cyclocoagulation // Am. J. Ophthalmol. – 1984. – V. 98. – P. 788-795.
83. Качанов А.Б. Диод-лазерная трансклеральная контактная циклокоагуляция в лечении различных форм глауком и офтальмогипертензий (экспериментально-клиническое исследование): Автореф. дис. … канд. мед. наук. – СПб., 1998. – 30 с.
84. Балашевич Л.И., Березин Ю.Д., Бой-ко Э.В., Гацу А.Ф. Лазерные технологии в клинической офтальмологии. – СПб., 1998. – 30 с.
85. Peyman G., Naguib K., Caasterland D. Transscleral application of a semiconductor diode laser // Lasers in Surg. and Med. – 1990. – V. 10. – P. 569-575.
86. Жданова Л., Даль Н., Кузнецова Н. Противовоспалительная терапия после диод-лазерной циклокоагуляции у больных с неоваскулярной глаукомой // Офтальмологические ведомости. – 2008. – Т. 1. – № 1. – С. 52-55.
87. Oguri A., Takahashi E., Tomita G. et al. Transscleral cyclophotocoagulation with the diode laser for neovascular glaucoma // Ophthalmic. Surg. Lasers. – 1998. – V. 29. – P. 722-727.
88. Bloom P.A., Tsai J.C., Sharma K. et al. «Cyclodiode». Transscleral diode laser cyclophotocoagulation in the treatment of advanced refractory glaucoma // Ophthalmology. – 1997. – V. 104. – P. 1508—1519.
89. Shields M.B., Shields S.E. Noncontact transscleral Nd:YAG cyclophoto-coagulation: a long-term follow-up of 500 patients // Trans. Am. Ophthalmol. Soc. – 1994. – V. 92. – P. 271-283.
90. Bietti G. Surgical intervention on the ciliary bogy. New trends for the relief of glaucoma // JAMA. – 1950. – V. 142. – P. 889-897.
91. Krupin T., Johnson M.F., Becker B. Anterior segment ischemia after cyclocryotherapy // Am. J. Ophthalmol. – 1977. – V. 84. – P. 426-428.
92. Caprioli J., Strang S.L., Spaeth G.L., Poryzees E.H. Cyclocryotherapy in the treatment of advanced glaucoma // Ophthalmology. – 1985. – V. 92. – P. 947-954.
93. Sautter H., Demeler U. Antiglaucoma-tous ciliary body excision // Am. J. Ophthal-mol. – 1984. – V. 98. – P. 344-348.